Newtec vascular products Ltd
Newtec Vascular Products Ltd is developing a device which addresses Neo Intimal Hyperplasia – the blockage of vessels by scar tissue as a result of vascular graft surgery. The device has shown good efficacy in pre-clinical studies and Newtec are currently preparing for their first-in-man trials. Flo-Guard has the potential to be used in more than 2 million procedures per year with a market potential of more than £800m. The company is not a UCL spin out, however, UCLB acquired an equity shareholding as consideration for the assignment of IP (hernia mesh and surgical clip technologies).
Year founded: 2013